Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.
Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T. Mirian C, et al. Among authors: broholm h. J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10. J Neurol Neurosurg Psychiatry. 2020. PMID: 32041819 Free article. Review.
TERT promoter mutations in primary and secondary WHO grade III meningioma.
Maier AD, Stenman A, Svahn F, Mirian C, Bartek J Jr, Juhler M, Zedenius J, Broholm H, Mathiesen T. Maier AD, et al. Among authors: broholm h. Brain Pathol. 2021 Jan;31(1):61-69. doi: 10.1111/bpa.12892. Epub 2020 Sep 15. Brain Pathol. 2021. PMID: 32805769 Free PMC article.
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.
Mirian C, Duun-Henriksen AK, Maier A, Pedersen MM, Jensen LR, Bashir A, Graillon T, Hrachova M, Bota D, van Essen M, Spanjol P, Kreis C, Law I, Broholm H, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Walter MA, Mathiesen T. Mirian C, et al. Among authors: broholm h. J Nucl Med. 2021 Apr;62(4):507-513. doi: 10.2967/jnumed.120.249607. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859705 Free article.
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma.
Mirian C, Grell K, Juratli TA, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Jensen LR, Schackert G, Broholm H, Scheie D, Cahill DP, Brastianos PK, Skjøth-Rasmussen J, Fugleholm K, Ziebell M, Munch TN, Kristensen BW, Mathiesen T. Mirian C, et al. Among authors: broholm h. Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12773. doi: 10.1111/nan.12773. Epub 2021 Dec 1. Neuropathol Appl Neurobiol. 2022. PMID: 34799864
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
Jensen LR, Maier AD, Lomstein A, Graillon T, Hrachova M, Bota D, Ruiz-Patiño A, Arrieta O, Cardona AF, Rudà R, Furtner J, Roeckle U, Clement P, Preusser M, Scheie D, Broholm H, Kristensen BW, Skjøth-Rasmussen J, Ziebell M, Munch TN, Fugleholm K, Walter MA, Mathiesen T, Mirian C. Jensen LR, et al. Among authors: broholm h. Neurosurg Rev. 2022 Oct;45(5):3067-3081. doi: 10.1007/s10143-022-01849-6. Epub 2022 Aug 19. Neurosurg Rev. 2022. PMID: 35984552 Review.
102 results